April 24, 2025 — Significant proposed regulatory changes within the U.S. Food and Drug Administration (FDA), along with large layoffs that have occurred across the U.S. Department of Health and Human Services (HHS) – which oversees the FDA – could greatly affect seafood importers, processors, and other industry stakeholders in the near future, according to a former FDA seafood specialist.
The recent HHS layoffs, which total nearly 20,000, include personnel with expertise in seafood, traditional foods, and labeling, “leaving the FDA with lack of expertise in these areas,” said Brian Ravitch, a senior regulatory advisor at Washington, D.C., U.S.A.-based law firm Olsson Frank Weeda who also worked at the FDA for 25 years, including time spent as a seafood specialist.
Read the full story at SeafoodSource